There is limited information on contemporary incidence rates and trends, by race, ethnicity, and age, for major subtypes of esophageal and gastric cancer in the United States. We examined the most recent nationwide incidence data for esophageal squamous cell carcinoma, esophageal adenocarcinoma (EAC), gastric cardia adenocarcinoma (GCA), and gastric non-cardia adenocarcinoma (GNCA) by race, ethnicity, and age in the United States.
A bout 17,290 newly diagnosed esophageal cancer cases and 15,850 deaths are expected to occur in the United States in 2018. 1 The corresponding estimates for gastric cancer are 26,240 cases and 10,800 deaths. 1 Major subtypes of esophageal and gastric cancer have common established risk factors that can greatly contribute to their occurrence in the United States. Smoking is a risk factor for all major subtypes, although the association is strongest for esophageal squamous cell carcinoma (ESCC). [2] [3] [4] Other major risk factors differ by cancer subtype and include heavy alcohol drinking for ESCC, excess body weight and gastroesophageal reflux disease (GERD) for esophageal adenocarcinoma (EAC) and gastric cardia adenocarcinoma (GCA), and Helicobacter pylori infection for gastric noncardia adenocarcinomas (GNCA). [2] [3] [4] [5] Previous studies report decreases in ESCC and GNCA rates over the past several decades, following substantial declines in prevalence of smoking and H pylori infection in the United States. [6] [7] [8] However, more recent studies reported increases in GNCA rates among young white and Hispanic women. 8 In contrast, increasing rates of EAC and GCA in the United States were observed from the 1970s, a trend mainly attributed to the obesity epidemic. 9, 10 Subsequently, the increase in EAC rates slowed during the mid-2000s and GCA rates plateaued during the 1990s. 9, 11 More recently, however, a study of EAC and GCA reported a decreasing trend in EAC rates in men and an increasing trend for GCA in men and women from 2005 to 2014. 12 Nevertheless, previous studies are outdated or are limited for other reasons. Some examined trends for all race-ethnicities and all ages combined rather than by race-ethnicity and age 12 despite substantial differences in prevalence of known risk factors for the diseases across racial-ethnic and age groups. [13] [14] [15] As such, overall incidence trends may mask important trends among subpopulations. Furthermore, most of the previous studies were based on data from the Surveillance, Epidemiology, and End Results Program, 9, 10, 16 which covers 10%-28% of the US population, and may not be representative of the entire population, especially for analysis by race-ethnicity. Herein, we examine contemporary incidence rates and trends for ESCC, EAC, GCA, and GNCA in the United States by race-ethnicity and age group using nationwide, high-quality population-based cancer registry data.
Methods

Incidence Data
Population-based cancer incidence data in the United States are collected by the National Cancer Institute's Surveillance, Epidemiology, and End Results Program and the Centers for Disease Control and Prevention's National Program of Cancer Registries and are compiled by the North American Association of Central Cancer Registries. For this analysis, we used incidence data from 35 US states, representing 79% of the US population, to provide incidence rates during 2010-2014 and trends from 1997 through 2014. 17 Data from Illinois, Kansas, Minnesota, Nevada, New Mexico, and Vermont were not included because these states did not submit data, failed to meet North American Association of Central Cancer Registries high-quality standards for 1 or more years during this period, or did not consent to participate in this study. We excluded 9 additional states (Alabama, Arkansas, Maryland, Mississippi, Missouri, North Dakota, South Dakota, Tennessee, and Virginia) and the District of Columbia because data were not available for 1 or more years during 1997-2014. Rates for American Indians/Alaska Natives are based on data from Contract Health Service Delivery Area counties.
International Classification of Diseases for Oncology, third edition, site codes were used to define cancers of the esophagus (C15.0-C15.9), gastric cardia (C16.0), and gastric noncardia (C16.1-C16.5) by histologic subtype: squamous cell carcinoma (8050-8078) and adenocarcinoma (8140-8573). Other/unspecified esophageal cancers were defined as those with any histologies other than squamous cell carcinoma or adenocarcinoma (including unspecified). Gastric cancers with topography codes C16.6, C16.8, or C16.9 or any histologies other than adenocarcinoma were classified as other/unspecified. Incidence trends for other/unspecified gastric cancers are shown, because they constituted more than one-fourth of all gastric cancers. Rates for other/unspecified esophageal cancers are not shown because of their relatively small numbers of cases. The topography code for cardia (C16.0) includes gastric cardia and cardioesophageal junction cancers. 11 However, because of anatomic proximity and unclear classification systems, the cardioesophageal junction cancer in some cases might be classified as EAC or GCA by health care providers at the time of diagnosis. 11 Therefore, we did an additional analysis combining these 2 subtypes.
Statistical Analysis
All incidence rates were age-standardized to the 2000 US standard population and were calculated using the National Cancer Institute's SEER*Stat software. We examined trends in esophageal and gastric cancer incidence rates from 1997 to 2014 using Joinpoint software version 4.5.0.1 (National Cancer Institute). We allowed a maximum of 2 joinpoints in these analyses. The direction and magnitude of the resulting trends over the 1997-2014 period are described as the annual percent change. Incidence rates were adjusted for delays in reporting to account for the additional time required for registration of some cases. Because of sparse data, we only provided contemporary incidence rates but not incidence trends for American Indians/Alaska Natives. More detailed information on data sources and statistical analysis is provided in the Supplementary Methods section.
What You Need to Know
Background There is limited information on incidence trends by race, ethnicity, and age for major subtypes of esophageal and gastric cancer in the United States. We examined these trends using high-quality nationwide data (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) .
Findings
Despite declines in overall esophageal and gastric cancer incidence rates, we found increasing incidence trends for esophageal adenocarcinoma, gastric cardia adenocarcinoma, and gastric noncardia adenocarcinoma in several subpopulations, particularly in younger age groups.
Implications for patient care
Reducing exposure to potentially modifiable risk factors, notably smoking and obesity, could reverse the observed increasing trends and further reduce the burden of esophageal and gastric cancers in the United States.
Results
A total of 562,794 esophageal and gastric cancer cases were diagnosed from 1997 through 2014 in the 35 states included in this analysis (Supplementary Table 1 ). During 2010-2014, gastric cancer incidence rates were higher than esophageal cancer rates in all sex and racial-ethnic groups, except non-Hispanic (NH) white men, among whom rates were comparable (8.6 and 8.7 per 100,000, respectively) ( Figure 1) . Incidence rates for esophageal and gastric cancers and their subtypes were higher in men than in women in all racialethnic groups.
During 1997-2014, incidence rates for all esophageal and gastric cancers combined decreased among men and women across all racial-ethnic groups, with smaller decreases in NH whites than in other racialethnic groups (Supplementary Table 2 ). However, in analyses by age group, the rates increased in NH white women aged <60 years and Hispanic women aged <40 and were stable in other younger women and younger NH white and Hispanic men. Incidence trends for major subtypes of esophageal and gastric cancer are highlighted next.
Esophageal Squamous Cell Carcinoma
ESCC incidence rates continuously declined during 1997-2014 in both sexes in all racial-ethnic groups (Table 1, Figure 2) , with the sharpest decreases among NH black men and women. Decreasing trends were observed in almost all age groups, although rates were stable among NH white women aged <60 years (Supplementary Table 2 ).
Esophageal Adenocarcinoma
Among men, EAC rates in Hispanics and NH whites showed an initial increase from 1997 to 2006 and 2007, but rates decreased afterward in Hispanics and stabilized in NH whites (Table 1, Figure 2 ). EAC rates among Asian/ PI men showed a consistently increasing trend throughout the study period. Among women, EAC rates in NH whites increased during 1997-2014. There were no statistically significant trends in the other sex and racial-ethnic groups.
By age group, EAC rates in NH whites continuously increased throughout the study period in younger men (<50 years) and in most age groups among women (<70 years) ( Table 2) , with the largest increase in the youngest age group in both men (0-39 years) and women (40-49 years). Among older NH white men and women, EAC rates initially increased until the mid2000s but leveled off or decreased afterward. Data were sparse for most age groups in other racial-ethnic groups, particularly among women, and therefore are not shown.
Gastric Cardia Adenocarcinoma
Among men, GCA incidence rates in NH whites decreased from 1997 to 2008 and stabilized afterward, but they continuously decreased in Hispanics and Asian/ PIs (Table 1, Figure 2 ). Among women, GCA rates continuously increased among NH whites but decreased among Asian/PIs.
GCA incidence rates increased in most age groups among NH white men; the increase was continuous from 1997 through 2014 in ages 70 years, but it occurred from the mid-2000s in ages 40-69 years following an initial declining trend (Supplementary Table 2 ). Other trends by age group generally followed overall trends as described previously, although they were not statistically significant in several age and racial-ethnic groups with modest numbers of GCA cases.
Esophageal Adenocarcinoma and Gastric Cardia Adenocarcinoma Combined
When we combined EAC and GCA rates to minimize effects of any subtype misclassifications, EAC/GCA rates increased in NH white men (annual percent change, 2. Figure 2 ). In contrast, EAC/GCA rates decreased in Asian/PI women throughout the study period and in Hispanic men since 2007. EAC/GCA rates were stable in NH black men and women during 1997-2014.
Gastric Noncardia Adenocarcinomas
GNCA incidence rates continuously declined during 1997-2014 in both sexes and in all racial-ethnic groups (Table 1, Figure 2 ), and in most age groups among NH black men and Asian/PI men and women (Table 2) . However, there was a substantial variation in trends by age in NH whites and Hispanics, particularly among women. In general, rates decreased in older ages but were stable or increased in younger age groups. For example, GNCA rates in NH white and Hispanic women increased in ages <50 years, did not change in ages 50-59, and decreased in ages 60 years. GNCA rates among NH black women showed a similar pattern, with an increase in ages <40 years and a decrease in ages 70 years.
Overall incidence rates for "other/unspecified" gastric cancers declined during 1997-2014 in both sexes and in all racial and ethnic groups. Among younger women, however, the rates increased in NH whites and remained stable in NH blacks and Hispanics (Supplementary Table 2 ).
Discussion
Our comprehensive analysis of contemporary nationwide incidence data for major subtypes of esophageal and gastric cancer identified several emerging trends. First, although overall EAC incidence rates are decreasing or stabilizing during the most recent time period in major racial-ethnic groups, consistent with previous findings for all races-ethnicities combined, 12 incidence rates continued to increase in several subpopulations, including NH white men aged <50 years, NH white women <70 years, and Asian/PI men (all ages combined). Second, we found that GNCA incidence rates increased not only among young NH white and Hispanic women, as previously reported, 8 but also among young men (all races-ethnicities combined) and young NH black women. We also found that previously reported increases in overall GCA rates among men and women 12 were confined to NH whites, whereas rates decreased among Hispanic men and Asian/PI men and women.
Excess body weight increases EAC and GCA risk, likely through an increase in GERD and chronic inflammatory state, although mechanisms of action are unknown.
2,3 GERD in some cases could lead to Barrett's esophagus, a columnar metaplasia of esophageal epithelium, but many EAC cases do not have a history of GERD or Barrett's esophagus. 2 A substantial increase in prevalence of obesity after 1960 (Table 3) 13 may largely explain an increase in EAC and GCA incidence rates in the United States. 11 A decrease in H pylori infection prevalence may have also contributed to an increase in EAC and GCA incidence rates, perhaps through an increase in gastroesophageal reflux, although more research on the nature of this association is needed. 18 Although excess body weight seems to be the main contributor to the increase in EAC and GCA rates in the United States over the past several decades, changes in prevalence of other risk factors, notably smoking, may have contributed to plateaued or decreased EAC or GCA rates in some age, sex, and racial-ethnic groups. Smoking prevalence in the United States has been decreasing at least since the 1960s among men and the 1970s-1980s among women. 19 However, because of lack of sufficient information on latency periods and individual-level exposure information, we are not able to disentangle any temporal effects of changes in excess body weight and smoking prevalence, or of any other risk factors, on EAC and GCA occurrence. More research is also needed on the effects of proton pump inhibitors, which are used to alleviate GERD symptoms and heal reflux esophagitis, on ECA and GCA occurence. 20, 21 GNCA overall incidence rates have been declining following a substantial decrease in the prevalence of its primary risk factor, H pylori infection, in the United States since about the middle of last century. 15 However, GNCA incidence rates have increased in young adults during the most recent time period. Reasons for this increase are unclear but may include changes in demographics (eg, an increase in the proportion of those born in countries with a higher H pylori infection rates), 22 unhealthy diet (eg, consumption of processed meat), 5 changes in digestive tract microbiomes, 8 and a substantial increase in smoking prevalence among youth in the 1990s. 19 There is limited information on H pylori prevalence in the United States. One study found that the prevalence of H pylori increased between 1988-1991 and 1999-2000 among NH whites aged 20-29 years, but decreased in other age groups. 15 However, those estimates were based on relatively small numbers of participants. We did not examine trends for intestinal and diffuse subtypes of noncardia cancers because of a high proportion of tumors with unspecified morphology (data not shown). As such, the only statistically significant changes in a previous study of NH whites during 1995-2013 were for unspecified morphology (increase in ages <50 [women only]; decrease in ages 50 years), except for a decrease in diffuse subtype in older people. 8 The overall decrease in smoking prevalence is likely the major contributing factor to the decline in ESCC incidence rates. The stable trend in ESCC incidence rates among NH white women aged 40-59 may be related to the changing smoking patterns in women born in the 1960s and afterward, because it is consistent with female lung cancer death rates in recent decades in similar birth cohorts. 23 Although a recent increase in excessive alcohol consumption may have contributed to this trend, increased alcohol consumption has occurred in both men and women. 24 Differences in exposure to risk factors could largely explain gender and racial-ethnic disparities in ESCC and GNCA rates. Notably, prevalence of smoking and heavy alcohol drinking has historically been higher among men than women, 13, 24 and smoking and H pylori infection are more common among lower income people and among nonwhites in the United States (Table 3) . 13, 15 Although there is no nationally representative information on prevalence of H pylori infection among Asian/PIs, smallscale surveys have shown high prevalence among Asians, particularly among first-generation immigrants, reflecting high prevalence of the infection in their country of birth. 22 However, reasons for gender and racial-ethnic differences in EAC and GCA incidence rates are less clear. For example, despite higher smoking and excess body weight prevalence among NH black men compared with Asian/PI men (Table 3) , EAC/GCA incidence rates in = Figure 1 . Average incidence rates for esophageal and gastric cancer subtypes by sex and race-ethnicity, United States, 2010-2014. Average incidence rates are per 100,000 and age-adjusted to the 2000 US standard population. Rates for AIs/ANs are based on data from Contract Health Service Delivery Area counties. Statistic for "Other/unspecified" esophageal cancer in AI/AN women is not displayed because of fewer than 10 cases. Adeno., adenocarcinoma; AI/AN, American Indian/Alaska Native; PI, Pacific Islander; SCC, squamous cell carcinoma. these 2 groups are comparable. Similarly, although obesity prevalence is much lower in men than women in the United States, 13 incidence rates for EAC are 4-11 times higher in men than in women and 2-5 times higher for GCA. Some studies have suggested that women may be at a lower risk of esophageal and gastric cancers because of some reproductive or hormonal factors, but these associations need further investigation. [25] [26] [27] Because of relatively low incidence rates and high cost of endoscopy, screening of the general population for esophageal and gastric cancers in the United states has not been shown to be cost-effective. 28 However, major American gastroenterology organizations have recommended surveillance of high-risk individuals, such as some cases of Barrett's esophagus. 28 Our findings could be used to improve criteria for identifying highrisk subpopulations, although more research, particularly on novel biomarkers, is needed to develop precision screening programs.
Similar to the United States, ESCC incidence rates have decreased in recent decades in other high-income countries, some of which have also seen an increase in EAC rates. 4, 10 As a result, EAC has outnumbered ESCC in North America, Australia, New Zealand, and some North European countries. 29 In other populations, however, ESCC is still the prominent subtype of esophageal cancer, although incidence trends for ESCC and EAC are usually unknown. 4, 29 Incidence rates of gastric cancer are decreasing in most countries worldwide, but because of sparse high-quality, nationwide data by anatomic subtype, incidence trends for GCA and GNCA are generally less clear, even in some high-income countries. 4, 6, 10, 30 Because patterns of major risk factors in other populations are generally following those in high-income countries (eg, increasing obesity, declining H pylori infection), 10 overall trends in esophageal and gastric cancer subtypes worldwide are likely to follow the historical trends in high-income countries.
A strength of our study is the use of nationwide, highquality population-based data to document emerging incidence trends for esophageal and gastric cancer subtypes among racial-ethnic subpopulations. However, our study has several limitations. North American Association of Central Cancer Registries data on cancer subsite and histology may not be complete across states, but the completeness is at least 90%, and in most states 95%. 31 Data on race-ethnicity may be misclassified, and incidence data generally are available only for broad and heterogeneous racial-ethnic groups. For example, Asians/Pacific Islanders include subpopulations with vastly distinct cultural and health profiles, among which esophageal and gastric cancer rates may vary substantially. Furthermore, incidence rates in some age and racial-ethnic groups were based on a relatively modest number of esophageal or gastric cancer cases and should be interpreted with caution. Improved classification of gastric cancers from "unclassified" to "cardia" cancer 32 may have contributed to some but not all of the increase in GCA incidence rates, because incidence rates also increased for EAC, which shares similar major risk factors with GCA. Increasing or stable incidence trends for other/unspecified gastric cancers among younger 27.7
NOTE. Average incidence rates are age-adjusted to the 2000 US standard population. APC, annual percent change; EAC, esophageal adenocarcinoma; GNCA, gastric noncardia adenocarcinoma.
a Data on EAC were sparse for most age groups in other racial-ethnic groups and therefore are not shown. b The APC is significantly different from 0.0 (P < .05).
women indicate that improved classification of gastric cancers does not explain the increasing trend for GNCA in this group. We found that incidence rates for EAC and GNCA are increasing in several subpopulations in the United States. Although more research on factors contributing to these increasing trends is needed, intensified efforts to reduce exposure to established and potentially modifiable risk factors, notably smoking and excess body weight, could further reduce the burden of these cancers in the country.
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